INS and Alzheimer disease: Our data thus suggest that decreased cholesterol biosynthesis induced by the decreased expression of DHCR24 can result in an impairment of the insulin/IGF-1 signaling pathway, thereby leading to the impairment of synaptogenesis, neuronal function, and/or neuron death, all of which may contribute to the further impairment of the neurological functions, including AD.